NEW DELHI : Dr N K Arora, Chairman for India's Covid-19 Working group of National Technical Advisory Group on immunisation (NTAGI) on Tuesday confirmed that Corbevax, the country homegrown vaccine against the novel coronavirus is safe.
Dr. Arora also confirmed that Corbevax offers good immunogenicity and higher antibody levels than some other vector vaccines.
Corbevax has received the Drugs Controller General of India's Subject Expert Committee (SEC) recommendation for Emergency Use Authorization for the age group 12 to 18 years subject to certain conditions.
Corbevax is being created by Hyderabad-based pharmaceutical company Biological E. The country's central drug authority is expected to give final approval to Corbevax, which is a two-dose vaccine, soon, sources had said.